US Stock MarketDetailed Quotes

NTLA Intellia Therapeutics

Watchlist
  • 15.120
  • -0.990-6.15%
Close Nov 14 16:00 ET
  • 15.290
  • +0.170+1.12%
Pre 08:10 ET
1.54BMarket Cap-2774P/E (TTM)

Intellia Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Business Currency:USD
2023/FY
Stock NameRevenueRatio
Development of genome editing-based therapies36.28M100.00%
Region Currency:USD
2023/FY
Stock NameRevenueRatio
United States36.28M100.00%

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data

Concept Gene Editing
Gene Editing
Intraday-2.50%
ARK Portfolio
ARK Portfolio
Intraday-4.81%